Biotechnology Stocks
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2281 |  MNKD MannKind Corporation - Common Stock | 4.20 USD | -0.47% | -0.24% | +22.09% | -20.75% | 1.30 B USD | ||
| 2313 |  SVRA Savara, Inc. - Common Stock | 6.15 USD | -0.97% | +0.82% | +22.51% | +167.39% | 1.26 B USD | ||
| 2324 |  CAPR Capricor Therapeutics, Inc. - Common Stock | 21.47 USD | -3.38% | -10.20% | -19.04% | +105.26% | 1.24 B USD | ||
| 2330 |  WVE Wave Life Sciences Ltd. - Ordinary Shares | 6.22 USD | -2.51% | +4.71% | +8.17% | -13.13% | 1.20 B USD | ||
| 2351 |  EYPT EyePoint, Inc. - Common Stock | 13.83 USD | -1.36% | -6.05% | +20.47% | +15.25% | 1.16 B USD | ||
| 2372 |  XNCR Xencor, Inc. - Common Stock | 15.81 USD | +0.89% | -0.69% | +36.18% | +88.21% | 1.17 B USD | ||
| 2399 |  JBIO Jade Biosciences, Inc. - Common Stock | 22.03 USD | -1.87% | +0.18% | +45.89% | +119.20% | 1.09 B USD | ||
| 2401 |  ORIC Oric Pharmaceuticals, Inc. - Common Stock | 10.41 USD | -4.32% | -7.05% | +35.37% | -22.95% | 1.08 B USD | ||
| 2405 |  DRTS Alpha Tau Medical Ltd. - Ordinary Shares | 12.76 USD | 0.00% | -0.70% | +37.20% | +286.67% | 1.12 B USD | ||
| 2407 |  SLDB Solid Biosciences Inc. - Common Stock | 10.69 USD | -4.13% | +7.44% | +64.71% | +87.54% | 1.05 B USD | ||
| 2418 |  CGEM Cullinan Therapeutics, Inc. - Common Stock | 17.78 USD | -2.09% | +0.23% | +32.98% | +139.30% | 1.09 B USD | ||
| 2419 |  OLMA Olema Pharmaceuticals, Inc. - Common Stock | 11.76 USD | -6.89% | -2.33% | +15.29% | +43.59% | 1.03 B USD | ||
| 2421 |  SANA Sana Biotechnology, Inc. - Common Stock | 3.91 USD | -5.10% | +8.61% | +43.22% | -6.68% | 1.09 B USD | ||
| 2427 |  VOR Vor Biopharma Inc. - Common Stock | 19.25 USD | -4.23% | +4.51% | +44.63% | +46.95% | 1.04 B USD | ||
| 2449 |  KURA Kura Oncology, Inc. - Common Stock | 11.75 USD | -2.00% | +8.20% | +33.83% | +99.15% | 1.04 B USD | ||
| 2467 |  LBRX LB Pharmaceuticals Inc - Common Stock | 34.09 USD | -0.58% | +4.70% | +15.40% | +79.42% | 977.59 M USD | ||
| 2474 |  LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 2.26 USD | -4.64% | -5.83% | +20.21% | +148.35% | 1.00 B USD | ||
| 2475 |  PHAR Pharming Group N.V. - ADS, each representing 10 | 14.30 USD | -1.11% | +4.08% | +12.42% | +37.63% | 1.00 B USD | ||
| 2480 |  ABUS Arbutus Biopharma Corporation - Common Stock | 5.05 USD | -2.51% | +6.09% | +17.72% | +57.81% | 997.57 M USD | ||
| 2501 |  ANNX Annexon, Inc. - common stock | 5.98 USD | -7.00% | +7.55% | +15.22% | +118.25% | 979.78 M USD |
Nachrichten Biotechnology Stocks
BofA bestätigt Kaufempfehlung für Beam Therapeutics nach Schiedsspruch
ROUNDUP/Aktien Frankfurt Schluss: Waffenruhe im Iran wohl vorbei - Dax sackt ab
Schiedsspruch belastet Beam Therapeutics: Aktie fällt vom 52-Wochen-Hoch
Prime Medicine: Aktie legt nach Sieg im Rechtsstreit mit Beam Therapeutics deutlich zu
Incyte Aktie erreicht 52-Wochen-Hoch bei 118,77 USD
Prime Medicine Aktie steigt nach gewonnenem Schiedsverfahren gegen Beam
Quartalsbericht von Nurix Therapeutics: Roche-Partnerschaft im Fokus
Gainers Biotechnology Stocks
 TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.36 | +40.65% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0249 | +24.50% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.38 | +20.71% |
 APLMW Apollomics Inc. - Warrant | 0.0143 | +19.17% |
 CBUS Cibus, Inc. - Class A Common Stock | 1.76 | +17.33% |
 TTRX Turn Therapeutics Inc. - Common Stock | 11.37 | +17.10% |
 PRME Prime Medicine, Inc. - Common Stock | 4.57 | +14.54% |
 SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.41 | +13.25% |
Losers Biotechnology Stocks
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.05 | -25.99% |
 BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.84 | -19.23% |
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0140 | -16.67% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.16 | -12.04% |
 TVGNW Tevogen Bio Holdings Inc. - Warrant | 0.0501 | -11.64% |
 ONCO Onconetix, Inc. - Common Stock | 0.95 | -11.21% |